e-HERO 2.0 for HIV/AIDS

Northern Arizona University, Flagstaff, AZ
HIV/AIDSe-HERO: Ending the HIV Epidemic in Rural Oklahoma - Behavioral
17 - 29
What conditions do you have?

Study Summary

This trial seeks to reduce HIV & syphilis in rural OK men, by increasing testing, condom use & PrEP uptake. It will refine an intervention in partnership with local mentors & assess its impact.

Eligible Conditions

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 1 month and 3 months

Month 3
PrEP consult with medical provider
Month 3
HIV testing uptake
Month 3
Condom use
HIV testing intention
STI testing intention

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

e-HERO 1.0
1 of 2
e-HERO 2.0
1 of 2

Active Control

Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: e-HERO 2.0 · No Placebo Group · N/A

e-HERO 2.0
Experimental Group · 1 Intervention: e-HERO: Ending the HIV Epidemic in Rural Oklahoma · Intervention Types: Behavioral
e-HERO 1.0
ActiveComparator Group · 1 Intervention: e-HERO: Ending the HIV Epidemic in Rural Oklahoma · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month and 3 months

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
316 Previous Clinical Trials
1,322,793 Total Patients Enrolled
Northern Arizona UniversityLead Sponsor
25 Previous Clinical Trials
6,349 Total Patients Enrolled
Oklahoma State UniversityOTHER
39 Previous Clinical Trials
7,255 Total Patients Enrolled
Purdue UniversityOTHER
215 Previous Clinical Trials
65,835 Total Patients Enrolled
Julie Baldwin, Ph.D.Principal InvestigatorNorthern Arizona University

Eligibility Criteria

Age 17 - 29 · Male Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You identify as an American Indian or a man who is gay, bisexual, or has sex with other men. No need to provide proof of tribal enrollment for American Indian status.

Frequently Asked Questions

Who qualifies to participate in the experiment?

"Eligible candidates for this clinical trial must have HIV and fall between the ages of 17-29. Approximately 200 patients are needed to fulfill the goal of this project." - Anonymous Online Contributor

Unverified Answer

Are individuals over 45 years old eligible to join this research endeavor?

"The eligibility criteria of this clinical trial necessitates that participants must be between the ages of 17 and 29. In comparison, there are 149 studies for minors under 18 years old and 470 trials for senior citizens 65 or older." - Anonymous Online Contributor

Unverified Answer

What is the number of participants involved in this clinical experiment?

"Affirmative. Clinicaltrials.gov attests that this clinical trial is currently recruiting individuals with the first posting of December 1st 2022 and a recent update on December 16th 2022. 200 volunteers need to be enrolled from one medical centre for the study's completion." - Anonymous Online Contributor

Unverified Answer

Is recruitment currently underway for this trial?

"Affirmative. Documents posted to clinicaltrials.gov demonstrate that this medical trial, which was initially published on December 1st 2022, is presently seeking participants. Approximately 200 patients have been identified as necessary for the study across a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.